Adaptive Biotechnologies ... (ADPT)
NASDAQ: ADPT
· Real-Time Price · USD
9.04
0.13 (1.46%)
At close: May 16, 2025, 3:59 PM
9.22
2.05%
After-hours: May 16, 2025, 07:23 PM EDT
Adaptive Biotechnologies Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|
| Sequencing Revenue Revenue | 78.9M | 41.44M | 43.52M |
| Sequencing Revenue Revenue Growth | +90.39% | -4.78% | n/a |
| Development Revenue Regulatory Milestones Revenue | 10M | 2.5M | 2M |
| Development Revenue Regulatory Milestones Revenue Growth | +300.00% | +25.00% | n/a |
| Development Support Revenue Revenue | 65.45M | 54.44M | 39.55M |
| Development Support Revenue Revenue Growth | +20.21% | +37.65% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 40.45M | 39.63M | 37.81M | 37.53M | 41.92M | 42.63M | 40.57M | 46.17M | 43.14M | 46.14M | 42.27M | 45.48M | 50.24M | 50.04M | 45.1M | 39.28M | 35.54M | 31.94M | 26.55M | 26.57M | 25.83M | 20.83M | 17.58M | 15.56M | 14.82M | 14.57M | 10.78M | 9.96M | 9.59M |
| Selling, General, and Administrative Revenue Growth | +2.06% | +4.82% | +0.75% | -10.47% | -1.68% | +5.09% | -12.14% | +7.04% | -6.51% | +9.17% | -7.06% | -9.47% | +0.39% | +10.95% | +14.82% | +10.53% | +11.26% | +20.30% | -0.06% | +2.87% | +24.00% | +18.51% | +12.96% | +4.98% | +1.75% | +35.15% | +8.20% | +3.87% | n/a |
| Research and Development Revenue | 24.2M | 23.19M | 24.16M | 22.99M | 30.25M | 23.78M | 28.53M | 32.24M | 32.6M | 31.22M | 35.66M | 37.04M | 37.84M | 34.7M | 36.07M | 37.8M | 33.77M | 35.83M | 30.31M | 25.99M | 23.93M | 21.19M | 20.51M | 16.53M | 12.48M | 11.07M | 9.78M | 9.45M | 8.86M |
| Research and Development Revenue Growth | +4.36% | -4.02% | +5.09% | -23.98% | +27.17% | -16.65% | -11.49% | -1.12% | +4.42% | -12.44% | -3.72% | -2.12% | +9.05% | -3.81% | -4.57% | +11.93% | -5.75% | +18.20% | +16.63% | +8.59% | +12.96% | +3.33% | +24.08% | +32.40% | +12.79% | +13.12% | +3.50% | +6.74% | n/a |
| Sales and Marketing Revenue | 23.05M | 21.57M | 20.55M | 20.31M | 22.32M | 21.91M | 20.49M | 23.87M | 22.31M | 23.72M | 21.51M | 24.28M | 26.09M | 26.7M | 24.95M | 23.22M | 20.6M | 18.55M | 14.47M | 14.33M | 14.01M | 12.64M | 9.1M | 8.9M | 7.82M | 8.07M | 6.04M | 5.33M | 5.05M |
| Sales and Marketing Revenue Growth | +6.82% | +4.98% | +1.17% | -8.98% | +1.89% | +6.90% | -14.15% | +7.01% | -5.94% | +10.24% | -11.40% | -6.94% | -2.26% | +7.00% | +7.46% | +12.68% | +11.10% | +28.13% | +0.99% | +2.32% | +10.81% | +38.92% | +2.27% | +13.82% | -3.15% | +33.65% | +13.32% | +5.59% | n/a |